Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The first results from a 26-week trial indicate patients who used automated bolus advisors displayed improved glycemic control and treatment satisfaction without an increase for severe hypoglycemia.
?Our findings demonstrate that use of an automated bolus advisor can be efficacious and clinically meaningful in multiple daily insulin injection (MDI) therapy, and that most patients are willing and able to use this technology appropriately when adequate clinical support is provided,? Ralph Ziegler, MD, from the Diabetes Clinic for Children and Adolescents in Muenster, Germany, and colleagues wrote.
http://www.healio.com/endocrinology...mproved-glycemic-control-patient-satisfaction
?Our findings demonstrate that use of an automated bolus advisor can be efficacious and clinically meaningful in multiple daily insulin injection (MDI) therapy, and that most patients are willing and able to use this technology appropriately when adequate clinical support is provided,? Ralph Ziegler, MD, from the Diabetes Clinic for Children and Adolescents in Muenster, Germany, and colleagues wrote.
http://www.healio.com/endocrinology...mproved-glycemic-control-patient-satisfaction
